Department of Psychiatry, University of California, Davis, California, USA.
Department of Computer Science, University of California, Davis, California, USA.
Hum Brain Mapp. 2021 Mar;42(4):1197-1205. doi: 10.1002/hbm.25286. Epub 2020 Nov 13.
Previous work using logistic regression suggests that cognitive control-related frontoparietal activation in early psychosis can predict symptomatic improvement after 1 year of coordinated specialty care with 66% accuracy. Here, we evaluated the ability of six machine learning (ML) algorithms and deep learning (DL) to predict "Improver" status (>20% improvement on Brief Psychiatric Rating Scale [BPRS] total score at 1-year follow-up vs. baseline) and continuous change in BPRS score using the same functional magnetic resonance imaging-based features (frontoparietal activations during the AX-continuous performance task) in the same sample (individuals with either schizophrenia (n = 65, 49M/16F, mean age 20.8 years) or Type I bipolar disorder (n = 17, 9M/8F, mean age 21.6 years)). 138 healthy controls were included as a reference group. "Shallow" ML methods included Naive Bayes, support vector machine, K Star, AdaBoost, J48 decision tree, and random forest. DL included an explainable artificial intelligence (XAI) procedure for understanding results. The best overall performances (70% accuracy for the binary outcome and root mean square error = 9.47 for the continuous outcome) were achieved using DL. XAI revealed left DLPFC activation was the strongest feature used to make binary classification decisions, with a classification activation threshold (adjusted beta = .017) intermediate to the healthy control mean (adjusted beta = .15, 95% CI = -0.02 to 0.31) and patient mean (adjusted beta = -.13, 95% CI = -0.37 to 0.11). Our results suggest DL is more powerful than shallow ML methods for predicting symptomatic improvement. The left DLPFC may be a functional target for future biomarker development as its activation was particularly important for predicting improvement.
先前使用逻辑回归的研究表明,早期精神病患者的认知控制相关的额顶叶激活可以预测经过 1 年协调专业护理后症状改善的情况,准确率为 66%。在这里,我们使用相同的功能磁共振成像(fMRI)特征(AX 连续执行任务期间的额顶叶激活)评估了六种机器学习(ML)算法和深度学习(DL)预测“改善者”状态(1 年随访时简明精神病评定量表[BPRS]总分改善>20%,与基线相比)和 BPRS 评分连续变化的能力,同一样本中包含精神分裂症(n=65,49M/16F,平均年龄 20.8 岁)或 I 型双相情感障碍(n=17,9M/8F,平均年龄 21.6 岁)的个体。纳入 138 名健康对照作为参考组。“浅层”ML 方法包括朴素贝叶斯、支持向量机、K 星、自适应增强、J48 决策树和随机森林。DL 包括用于理解结果的可解释人工智能(XAI)程序。使用 DL 实现了最佳的总体性能(二元结果的准确率为 70%,连续结果的均方根误差=9.47)。XAI 显示左侧背外侧前额叶皮层的激活是进行二元分类决策的最强特征,分类激活阈值(调整后的β=0.017)介于健康对照组均值(调整后的β=0.15,95%CI=-0.02 至 0.31)和患者均值(调整后的β=-0.13,95%CI=-0.37 至 0.11)之间。我们的研究结果表明,DL 比浅层 ML 方法更适合预测症状改善。左侧背外侧前额叶皮层可能是未来生物标志物开发的功能靶点,因为其激活对于预测改善尤为重要。